McClusky LM, de Jager C, Bornman MS
GLP-1 and Dual GIP/GLP-1 Receptor Agonists: From Science to Practice April 10 @ 9:30 AM - May 11 @ 5:00 PM Join leading experts in endocrinology, obesity medicine, and clinical pharmacology for a deep dive into the evolving landscape of GLP-1 and Dual GIP/GLP-1 receptor agonists
Based on the information in the chart, all of our top picks should be generally safe for most healthy adults
The same principles of placement, hold time, empty stomach, and post-dose fasting apply equally
I can give any dose I wanted to give them and people will feel fine
Compounders generally have to follow widely accepted quality standards that lay out how often they need to monitor for contamination, what kinds of tests they need to perform on their drugs and other requirements